Zobrazeno 1 - 10
of 52
pro vyhledávání: '"J. Benraadt"'
Autor:
Harry Bartelink, P.J.M. van der Vaart, C.C.M. Koning, P. Rodrigus, D. González González, José Belderbos, Mia G. J. Koolen, Apollonia L.J. Uitterhoeve, J. Benraadt
Publikováno v:
European Journal of Cancer. 36:592-600
The purpose of this work was to study the feasibility of concurrent chemoradiation in patients with inoperable non-small cell lung cancer (NSCLC). 40 patients with inoperable NSCLC were treated with escalating doses of radiotherapy and cisplatin (cDD
Publikováno v:
The Netherlands Journal of Medicine. 49:228-234
Autor:
F.E. van Leeuwen, A.W. van den Belt-Dusebout, J. Benraadt, F.W. Diepenhorst, H. van Tinteren, J.W.W. Coebergh, L.A.L.M. Kiemeney, C.H.F. Gimbrère, R. Otter, L.J. Schouten, R.A.M. Damhuis, M. Bontenbal
Publikováno v:
The Lancet. 343:448-452
Since large trials have been set up to assess whether tamoxifen decreases the risk of breast cancer in healthy women, it has become important to investigate the drug's potential adverse effects, including occurrence of endometrial cancer. We undertoo
Autor:
Peter J. Koehler, Jan J. Heimans, J J van der Sande, J. Benraadt, Ch. J. Vecht, Willem Boogerd, Neil K. Aaronson, M. J. van den Bent, Augustinus A. M. Hart
Publikováno v:
Boogerd, W, van den Bent, M J, Koehler, P J, Heimans, J J, van der Sande, J J, Aaronson, N K, Hart, A A M, Benraadt, J & Vecht, C J 2004, ' The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study ', European Journal of Cancer, vol. 40, pp. 2726-2733 . https://doi.org/10.1016/j.ejca.2004.08.012
European Journal of Cancer, 40, 2726-2733. Elsevier Ltd.
European Journal of Cancer, 40, 2726-2733. Pergamon
European Journal of Cancer, 40, 2726-2733. Elsevier Ltd.
European Journal of Cancer, 40, 2726-2733. Pergamon
To assess the benefit of intraventricular chemotherapy, patients with leptomeningeal metastasis (LM) from breast cancer were randomised to treatment including intraventricular (IT) chemotherapy (n = 17) or to non-intrathecal (non-IT) treatment (n = 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fda0c542c5b713f67fdc516de219297c
https://research.vumc.nl/en/publications/f40d5854-732e-49e6-ab95-89e2000c6021
https://research.vumc.nl/en/publications/f40d5854-732e-49e6-ab95-89e2000c6021
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
Autor:
H. van Tinteren, J.C. Huldij, Jan B. Vermorken, Rob Michalides, P. J. Van Diest, A. Balkenende, J. Benraadt
Publikováno v:
The British journal of cancer
British Journal of Cancer
British Journal of Cancer
Overexpression of G1-S regulators cyclin D1 or cyclin A is frequently observed in breast cancer and is also to result in ligand-independent activation of oestrogen receptor in vitro. This might therefore, provide a mechanism for failure of tamoxifen
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 145(28)
To describe the diagnostic work-up and treatment of patients with a pancreatic carcinoma in the Amsterdam area, the Netherlands, particularly in general hospitals.Retrospective, descriptive.During 1997, 286 patients with a pancreatic carcinoma were d
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 145(28)
A project on the diagnostic work-up and treatment of distal bile duct and pancreatic carcinoma was carried out in the region covered by the Comprehensive Cancer Centre in Amsterdam, the Netherlands. It consisted of (a) describing the diagnostic work-
Autor:
G. J. A. Offerhaus, J. P. A. Baak, F. J. W. Ten Kate, J Benraadt, G. N. J. Tytgat, Jan B F Hulscher, Jelle Haringsma, J. J. B. van Lanschot
Publikováno v:
Netherlands journal of medicine, 58(1), 3-8. Van Zuiden Communications BV
Background: Treatment and follow-up policy for Barrett’s oesophagus are dependent on the grade of dysplasia. However, sampling error of random biopsy protocols and subjectivity of pathological grading may hamper endoscopic surveillance. Methods: Th
Publikováno v:
Lancet (London, England). 356(9233)
Tamoxifen increases the risk of endometrial cancer. However, few studies have produced reliable risk estimates by duration, dose, and recency of use, or addressed the prognosis of endometrial cancers in tamoxifen-treated women.We did a nationwide cas
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 141(10)
To calculate the cancer incidence in the region surrounding Schiphol.Descriptive epidemiological study based on cancer registry data.Comprehensive Cancer Centre Amsterdam. The Netherlands.Using noise levels expressed as Kosten-cenheden (Ke) of the ai